Access to anti-retroviral drugs, female in Algeria
Algeria: Access to anti-retroviral drugs, female was 65.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Algeria, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Algeria recorded 65.0% for access to anti-retroviral drugs, female in 2024.
Compared with earlier readings it is down 4.4% on the previous year and up 44.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Algeria peaked at 72.0% in 2019 and was at its lowest, 4.0%, in 2000.
Algeria ranks 91st of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Algeria, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 4.0% | — |
| 2001 | 5.0% | +25.0% |
| 2002 | 5.0% | +0.0% |
| 2003 | 5.0% | +0.0% |
| 2004 | 4.0% | -20.0% |
| 2005 | 6.0% | +50.0% |
| 2006 | 7.0% | +16.7% |
| 2007 | 8.0% | +14.3% |
| 2008 | 8.0% | +0.0% |
| 2009 | 15.0% | +87.5% |
| 2010 | 22.0% | +46.7% |
| 2011 | 24.0% | +9.1% |
| 2012 | 27.0% | +12.5% |
| 2013 | 37.0% | +37.0% |
| 2014 | 45.0% | +21.6% |
| 2015 | 53.0% | +17.8% |
| 2016 | 61.0% | +15.1% |
| 2017 | 65.0% | +6.6% |
| 2018 | 69.0% | +6.2% |
| 2019 | 72.0% | +4.3% |
| 2020 | 71.0% | -1.4% |
| 2021 | 72.0% | +1.4% |
| 2022 | 67.0% | -6.9% |
| 2023 | 68.0% | +1.5% |
| 2024 | 65.0% | -4.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.7% | 4.0% | 15.0% | 10 |
| 2010s | 47.5% | 22.0% | 72.0% | 10 |
| 2020s | 68.6% | 65.0% | 72.0% | 5 |
Countries ranked near Algeria
More gender data for Algeria
- Child population (UN estimates and projections) 13,418 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.77 % change on previous year (2030)
- Population 36,736 (2030)
- Working-age population (UN estimates and projections) 36,736 (2030)
- Population (UN estimates and projections), annual growth rate 2.06 % change on previous year (2030)
- Age population, age 00, female, interpolated 418,577 (2025)
- Age population, age 00, male, interpolated 436,436 (2025)
- Age population, age 01, female, interpolated 429,195 (2025)
- Age population, age 01, male, interpolated 447,420 (2025)
- Age population, age 02, female, interpolated 440,381 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Algeria?
- Access to anti-retroviral drugs, female in Algeria was 65.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Algeria?
- The highest recorded value was 72.0% in 2019.
- What is the lowest access to anti-retroviral drugs, female recorded in Algeria?
- The lowest recorded value was 4.0% in 2000.
- How does Algeria rank for access to anti-retroviral drugs, female?
- Algeria ranks 91st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Algeria?
- Over the last ten years it is up 44.4%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.